Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cardium Therapeutics has introduced a new high-potency bioavailable Vitamin D supplement, D-Sorb, to MedPodium's portfolio of Nutra-Apps lifestyle supplements.
Subscribe to our email newsletter
D-Sorb, avalaibale in small easy-to-swallow softgels, provides 2000 IUs of Vitamin D3.
The new Vitamin D supplement features SourceOne Global Partners’ VESIsorb lipid-based delivery system, which provides for increased absorption and bioavailability.
D-Sorb is intended to promote calcium absorption for healthy bones and to support the immune system and cardiovascular health.
Research has proven that Vitamin D may protect against osteoporosis, diabetes, hypertension, glucose intolerance, stroke, autoimmune diseases and some forms of cancer, such as prostrate, breast and colon cancers.
Cardium Therapeutics chairman and CEO Christopher Reinhard said they plan to continue to identify and evaluate additional science-based, easy-to-use lifestyle nutraceutical products to broaden the MedPodium healthy lifestyle brand platform for promoting health and well-being.
"The addition of D-Sorb represents an important step toward broadening the Company’s MedPodium Nutra-Apps healthy lifestyles brand platform and product portfolio," Reinhard said.